Related Experiment Video
Updated: May 13, 2026
09:21
Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
Published on: July 7, 2023
The BCL2 code to dopaminergic development and Parkinson's disease.
Lars P van der Heide1, Marten P Smidt
1Swammerdam Institute of Life Sciences, University of Amsterdam, Postbus 94232/1090 GE, Amsterdam, The Netherlands. L.P.vanderheide@Uva.nl
Trends in Molecular Medicine
|March 26, 2013
Summary
Cell death in the developing brain relies on BCL2 proteins. These same proteins may increase vulnerability to Parkinson's disease later in life, offering potential biomarkers and therapeutic targets.
Area of Science:
- Neuroscience
- Developmental Biology
- Molecular Biology
Background:
- Neuronal development requires precise cell death orchestration.
- Locally secreted growth factors and transcription factors regulate this process.
- Ensuring correct neuronal positioning and preventing "miswiring" is critical.
Purpose of the Study:
- To investigate the role of BCL2 proteins in dopaminergic system development and adult vulnerability.
- To explore the link between BCL2 proteins and Parkinson's disease.
- To identify potential biomarkers and therapeutic strategies for neurodegeneration.
Main Methods:
- The study hypothesizes BCL2 protein arrays execute cell death.
- It examines the dual role of these proteins in development and disease.
- The research connects BCL2 proteins to Parkinson's disease pathogenesis.
Main Results:
- BCL2 proteins are hypothesized to be the core machinery for programmed cell death.
- These proteins are essential for normal dopaminergic system development.
- Dysregulation or the presence of specific BCL2 proteins may contribute to adult dopaminergic system vulnerability.
Conclusions:
- BCL2 protein machinery is crucial for dopaminergic neuron development.
- These proteins present a potential link between normal development and Parkinson's disease.
- Further research may yield biomarkers for neurodegeneration and novel Parkinson's disease treatments.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...